Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) market cap up Mex$1.5b last week, benefiting both retail investors who own 38% as well as insiders

Key Insights

• The considerable ownership by retail investors in Genomma Lab Internacional. de indicates that they collectively have a greater say in management and business strategy
• The top 6 shareholders own 51% of the company
• Insiders own 33% of Genomma Lab Internacional. de

A look at the shareholders of Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) can tell us which group is most powerful. The group holding the most number of shares in the company, around 38% to be precise, is retail investors. Put another way, the group faces the maximum upside potential (or downside risk).

While retail investors were the group that reaped the most benefits after last week’s 7.6% price gain, insiders also received a 33% cut.

Let's delve deeper into each type of owner of Genomma Lab Internacional. de, beginning with the chart below.

Check out our latest analysis for Genomma Lab Internacional. de

What Does The Institutional Ownership Tell Us About Genomma Lab Internacional. de?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

Genomma Lab Internacional. de already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Genomma Lab Internacional. de's earnings history below. Of course, the future is what really matters.

Hedge funds don't have many shares in Genomma Lab Internacional. de. From our data, we infer that the largest shareholder is Rodrigo Alonso Aspra (who also holds the title of Top Key Executive) with 33% of shares outstanding. Its usually considered a good sign when insiders own a significant number of shares in the company, and in this case, we're glad to see a company insider play the role of a key stakeholder. In comparison, the second and third largest shareholders hold about 6.3% and 5.2% of the stock.

We did some more digging and found that 6 of the top shareholders account for roughly 51% of the register, implying that along with larger shareholders, there are a few smaller shareholders, thereby balancing out each others interests somewhat.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Genomma Lab Internacional. de

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our information suggests that insiders maintain a significant holding in Genomma Lab Internacional, S.A.B. de C.V.. It is very interesting to see that insiders have a meaningful Mex$6.9b stake in this Mex$21b business. Most would be pleased to see the board is investing alongside them. You may wish to access this free chart showing recent trading by insiders.

General Public Ownership

With a 38% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Genomma Lab Internacional. de. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Consider risks, for instance. Every company has them, and we've spotted 3 warning signs for Genomma Lab Internacional. de you should know about.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.